Literature DB >> 23817844

[Medicine from the computer].

K Andrae1, V Durmaz, K Fackeldey, O Scharkoi, M Weber.   

Abstract

Small molecules can have a significant effect on human metabolic processes. Computational drug design aims at constructing specialized small molecules that selectively and efficiently address specific proteins. The basic ideas of computational molecular design are presented and it will be shown how a virtual protein can be computer designed. This virtual protein can be used to predict the binding affinity of given small molecules without having to synthesize them in a laboratory. Modern computational drug design goes far beyond the lock and key principle. Possible future developments are discussed and a current successful example of computational drug design in the field of painkiller medication is demonstrated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817844     DOI: 10.1007/s00101-013-2202-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  13 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Quantifying the rebinding effect in multivalent chemical ligand-receptor systems.

Authors:  Marcus Weber; Alexander Bujotzek; Rainer Haag
Journal:  J Chem Phys       Date:  2012-08-07       Impact factor: 3.488

3.  Spanning binding sites on allosteric proteins with polymer-linked ligand dimers.

Authors:  R H Kramer; J W Karpen
Journal:  Nature       Date:  1998-10-15       Impact factor: 49.962

4.  Multivalency as a chemical organization and action principle.

Authors:  Carlo Fasting; Christoph A Schalley; Marcus Weber; Oliver Seitz; Stefan Hecht; Beate Koksch; Jens Dernedde; Christina Graf; Ernst-Walter Knapp; Rainer Haag
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-05       Impact factor: 15.336

Review 5.  Latest developments in molecular docking: 2010-2011 in review.

Authors:  Elizabeth Yuriev; Paul A Ramsland
Journal:  J Mol Recognit       Date:  2013-05       Impact factor: 2.137

6.  A new method for predicting binding affinity in computer-aided drug design.

Authors:  J Aqvist; C Medina; J E Samuelsson
Journal:  Protein Eng       Date:  1994-03

7.  A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro.

Authors:  S Kageyama; D T Hoekzema; Y Murakawa; E Kojima; T Shirasaka; D J Kempf; D W Norbeck; J Erickson; H Mitsuya
Journal:  AIDS Res Hum Retroviruses       Date:  1994-06       Impact factor: 2.205

8.  Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor.

Authors:  Min Shan; Kathryn E Carlson; Alexander Bujotzek; Anja Wellner; Ronald Gust; Marcus Weber; John A Katzenellenbogen; Rainer Haag
Journal:  ACS Chem Biol       Date:  2013-01-30       Impact factor: 5.100

9.  Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.

Authors:  I D Pogozheva; A L Lomize; H I Mosberg
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

10.  Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Authors:  Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; Jesper M Mathiesen; Roger K Sunahara; Leonardo Pardo; William I Weis; Brian K Kobilka; Sébastien Granier
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.